| Compound ID |
Compound Name |
Compound Formula |
|
CP0635477
|
(2-Carbamoyloxy-ethyl)-trimethyl-ammonium chloride
Show/Hide
|
C6H15ClN2O2
|
1
|
| 1 |
EC50 = 107.15 nM
|
|
|
|
CP0484339
|
4-[4-(3-methoxypyridin-2-yl)piperidin-1-yl]-1-pyrazin-2-ylazepane
Show/Hide
|
C21H29N5O
|
1
|
| 1 |
EC50 = 250 nM
|
|
|
|
CP0411100
|
2-[(1S,5R)-6-(1-phenylimidazol-2-yl)-3-azabicyclo[3.1.0]hexan-3-yl]-6-pyrazin-2-yl-6-azaspiro[3.4]octane
Show/Hide
|
C25H28N6
|
1
|
| 1 |
EC50 = 420 nM
|
|
|
|
CP0484340
|
US10030012, Example 38
Show/Hide
|
C20H31N3O3
|
1
|
| 1 |
EC50 = 2520 nM
|
|
|
|
CP0440162
|
CHEMBL4583597
Show/Hide
|
C24H30N4O2
|
1
|
| 1 |
EC50 = 5160 nM
|
|
|
|
CP0473747
|
ethyl 2-[4-(3-methoxypyridin-2-yl)piperidin-1-yl]-6-azaspiro[3.4]octane-6-carboxylate
Show/Hide
|
C21H31N3O3
|
1
|
| 1 |
EC50 > 10000 nM
|
|
|
|
CP0560056
|
2-[4-(3-methoxypyridin-2-yl)piperidin-1-yl]-6-pyrazin-2-yl-6-azaspiro[3.4]octane
Show/Hide
|
C22H29N5O
|
1
|
| 1 |
EC50 > 7350 nM
|
|
|
|
CP0416210
|
2-[4-[[4-(3-methoxypyridin-2-yl)piperidin-1-yl]methyl]piperidin-1-yl]pyrazine
Show/Hide
|
C21H29N5O
|
1
|
| 1 |
EC50 > 8830 nM
|
|
|
|
CP0109931
|
ATROPEN
Show/Hide
|
C17H23NO3
|
1
|
| 1 |
IC50 = 8.128 nM
|
|
|
|
CP0383958
|
(2S)-2-acetamido-6-amino-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]pentan-2-yl]amino]-1-oxopropan-2-yl]hexanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
C57H78F15N13O16
|
1
|
| 1 |
IC50 = 10.47 nM
|
|
|
|
CP0852609
|
N1,N3-Bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5Hdibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)-5-(propionamidomethyl)-isophthalamide Tetrakis(hydrotrifluoroacetate)
Show/Hide
|
C84H95F12N15O17
|
3
|
| 1 |
IC50 = 16.6 nM
|
|
|
| 2 |
IC50 = 173.78 nM
|
|
|
| 3 |
IC50 = 263.03 nM
|
|
|
|
CP0416405
|
4-[2-[(1E,3E,5E)-5-[1-[6-[[3,5-bis[2-[3-[1-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]imidazol-4-yl]propanoylamino]ethylcarbamoyl]phenyl]methylamino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-2-ylidene]penta-1,3-dienyl]-3,3-dimethylindol-1-ium-1-yl]butane-1-sulfonate;2,2,2-trifluoroacetic acid
Show/Hide
|
C114H132F9N17O21S2
|
2
|
| 1 |
IC50 = 17.38 nM
|
|
|
| 2 |
IC50 = 23.99 nM
|
|
|
|
CP0446632
|
3-[1-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]imidazol-4-yl]-N-[2-(propanoylamino)ethyl]propanamide
Show/Hide
|
C35H45N7O4
|
3
|
| 1 |
IC50 = 33.88 nM
|
|
|
| 2 |
IC50 = 85.11 nM
|
|
|
| 3 |
IC50 = 354.81 nM
|
|
|
|
CP0390408
|
4-[2-[(1E,3E,5E)-5-[3,3-dimethyl-1-[6-oxo-6-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]hexyl]-5-sulfoindol-2-ylidene]penta-1,3-dienyl]-3,3-dimethylindol-1-ium-1-yl]butane-1-sulfonate;2,2,2-trifluoroacetic acid
Show/Hide
|
C69H86F6N8O13S2
|
2
|
| 1 |
IC50 = 38.9 nM
|
|
|
| 2 |
IC50 = 223.87 nM
|
|
|
|
CP0390406
|
4-[(2Z)-2-[(2E,4E)-5-[3,3-dimethyl-1-[6-oxo-6-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethylamino]hexyl]indol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate;2,2,2-trifluoroacetic acid
Show/Hide
|
C71H87F9N8O12S
|
2
|
| 1 |
IC50 = 48.98 nM
|
|
|
| 2 |
IC50 = 60.26 nM
|
|
|
|
CP0396867
|
4-[2-[(1E,3E,5E)-5-[3,3-dimethyl-1-[6-oxo-6-[2-[3-[1-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]imidazol-4-yl]propanoylamino]ethylamino]hexyl]-5-sulfoindol-2-ylidene]penta-1,3-dienyl]-3,3-dimethylindol-1-ium-1-yl]butane-1-sulfonate;2,2,2-trifluoroacetic acid
Show/Hide
|
C69H84F3N9O12S2
|
2
|
| 1 |
IC50 = 57.54 nM
|
|
|
| 2 |
IC50 = 354.81 nM
|
|
|
|
CP0384594
|
(2S)-2-acetamido-6-amino-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butylamino]pentan-2-yl]hexanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
C44H59F9N10O11
|
1
|
| 1 |
IC50 = 93.33 nM
|
|
|
